|
COMMERCE BUSINESS DAILY ISSUE OF OCTOBER 14,1998 PSA#2200Department of Veterans Affairs, National Acquisition Center, P.O. Box
76, Bldg. 37, Hines, IL 60141-0076 66 -- PROCUREMENT OF TDX FLX THERAPEUTIC DRUG ANALYZER SOL M6-Q1-99
DUE 102698 POC Jane Brusveen (708) 786-7659 This is a combined
synopsis/solicitation for commercial items prepared in accordance with
the format in Subpart 12.6, as supplemented with additional
information included in this notice. This announcement constitutes the
only solicitation; proposals are being requested and a written
solicitation will not be issued. This procurement is considered for
noncompetitive contracting action. Solicitation M6-Q1-99 is being
issued as a Request for Quotation (RFQ). The solicitation document and
incorporated provisions and clauses are those in effect through
Federal Acquisition Circular 97-08. For informational purposed only:
The Department of Veterans Affairs, Office of Acquisition and Materiel
Management, National Acquisition Center, Hines, IL, intends to
contract on behalf of the U.S. Air Force AFMLO at Ft. Worth, Texas, 1
(one) TDx FLx Therapeutic Drug Analyzer from Abbott Laboratories
(Abbott) with all appropriate Abbott software updates. This procurement
is considered for noncompetitive contracting action due to the fact
that the supplies for this analyzer have already been purchased by the
USAF and Abbott supplies can only be used with the Abbott TDx FLx
Analyzer because of the packaging specifications of the supplies.
System description specifications are: sample carousel capacity is 1 to
20 samples; reagent carousel is 1 to 8 TDx FLx wedge reagent packs;
sample volume is 50 to 500 ul; carry over is <1.5% at concentrations
greater than or equal to the highest calibrator, unless otherwise
specified; intensity/stability is better than 0.1% over the duration of
an assay, and polarization range is 0 to 500 mP. Analyzer must have all
appropriate Abbott software updates. Delivery will be FOB Destination
and acceptance approximately 60 days after receipt of order to
AFMLO/OL-2, 501 Felix Street, Building 6, Ft. Worth, TX 76115.
Provisions 52.212-1, Instruction to Offerors -- Commercial, 52.212.4
Contract Terms and Conditions -- Commercial Items, and 52.212-5,
Contract Terms and Conditions Required to Implement Statutes or
Executive Orders -- Commercial Items apply. Provision 52.212-2
Evaluation -- Commercial Items applies using the following factors
listed in their order of importance to evaluate the offer: (i)
technical capability of the item offered to meet the Government
requirement; (ii) price; (iii) past performance -- 2 (two) recent
customers who purchased the TDx FLx Analyzer listing a point of
contact, address, purchase order number, and telephone number. Also, a
completed copy of provision 52.212-3, Offeror Representations and
Certifications -- Commercial Items, must be submitted with quote. Only
devices that have received Premarket Notification Approval from the
U.S. Food and Drug Administration (FDA) shall be considered for award
under this solicitation. Offeror must furnish proof of FDA 510(k)
Premarket Notification approval with this Request for Quotation. The
offeror shall enter, in the block with its name and address on the RFP,
the annotation "DUNS" followed by the DUNS number that identifies the
offeror's name and address exactly as stated in the offer. Quote,
completed provision 52.212-3, and past performance information are due
back to the VA National Acquisition Center, Medical Equipment
Division, P.O. Box 76, Hines, IL 60141, by 3:00 p.m. (local time) on
10/26/98. If you have any questions concerning this CBD
synopsis/solicitation, please contact Jane Brusveen at (708) 786-7659
or fax your response to (708) 786-5256. Posted 10/09/98 (W-SN261017).
(0282) Loren Data Corp. http://www.ld.com (SYN# 0217 19981014\66-0004.SOL)
66 - Instruments and Laboratory Equipment Index Page
|
|